Clonal distribution of common pneumococcal serotypes not included in the 7-valent conjugate vaccine (PCV7): Marked differences between two ethnic populations in southern Israel

Journal of Clinical Microbiology

Volumn 50, Issue 11, 2012, Pages 3472-3477

  Porat, Nurith ^a   Benisty, Rachel ^a   Trefler, Ronit ^a   Givon Lavi, Noga ^a   Dagan, Ron ^a  

^a BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

PNEUMOCOCCUS VACCINE;

ACUTE OTITIS MEDIA; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARAB; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; CHILD; CLONAL VARIATION; CONTROLLED STUDY; ETHNIC DIFFERENCE; HUMAN; ISRAEL; JEW; MAJOR CLINICAL STUDY; NONHUMAN; PNEUMOCOCCAL INFECTION; PRESCHOOL CHILD; PRIORITY JOURNAL; PROSPECTIVE STUDY; SEROTYPE; STREPTOCOCCUS PNEUMONIAE; VACCINATION;

ANTI-BACTERIAL AGENTS; CHILD, PRESCHOOL; CLUSTER ANALYSIS; ELECTROPHORESIS, GEL, PULSED-FIELD; ETHNIC GROUPS; FEMALE; GENOTYPE; HUMANS; INFANT; INFANT, NEWBORN; ISRAEL; MALE; MICROBIAL SENSITIVITY TESTS; MULTILOCUS SEQUENCE TYPING; PNEUMOCOCCAL INFECTIONS; PROSPECTIVE STUDIES; SEROTYPING; STREPTOCOCCUS PNEUMONIAE;

EID: 84867533177     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.01309-12     Document Type: Article

References (33)

1. Balicer RD, et al. 2010. Control of Streptococcus pneumoniae serotype 5 epidemic of severe pneumonia among young army recruits by mass antibiotic treatment and vaccination. Vaccine 28:5591-5596.
2. Beall B, et al. 2006. Pre- and postvaccination clonal compositions of invasive pneumococcal serotypes for isolates collected in the United States in 1999, 2001, and 2002. J. Clin. Microbiol. 44:999-1017.
3. Brueggemann AB, et al. 2003. Clonal relationships between invasive and carriage Streptococcus pneumoniae and serotype- and clone-specific differences in invasive disease potential. J. Infect. Dis. 187:1424-1432. (Pubitemid 36549688)
4. Brueggemann AB, et al. 2004. Temporal and geographic stability of the serogroup-specific invasive disease potential of Streptococcus pneumoniae in children. J. Infect. Dis. 190:1203-1211. (Pubitemid 39287745)
5. Byington CL, et al. 2006. Impact of the pneumococcal conjugate vaccine on pneumococcal parapneumonic empyema. Pediatr. Infect. Dis. J. 25:250-254. (Pubitemid 43379067)
6. Dagan R. 2009. New insights on pneumococcal disease: what we have learned over the past decade. Vaccine 27:C3-C5.
7. Dagan R. 2009. Serotype replacement in perspective. Vaccine 27:C22-C24.
8. Dagan R, Givon-Lavi N, Leibovitz E, Greenberg D, Porat N. 2009. Introduction and proliferation of multidrug-resistant Streptococcus pneumoniae serotype 19A clones that cause acute otitis media in an unvaccinated population. J. Infect. Dis. 199:776-785.
9. Enright MC, Spratt BG. 1998. A multilocus sequence typing scheme for Streptococcus pneumoniae: identification of clones associated with serious invasive disease. Microbiology 144:3049-3060. (Pubitemid 28515583)
10. Eskola J, et al. 2001. Efficacy of a pneumococcal conjugate vaccine against acute otitis media. N. Engl. J. Med. 344:403-409. (Pubitemid 32128672)
11. Green MC, et al. 2011. Increase in prevalence of Streptococcus pneumoniae serotype 6C at eight children's hospitals in the United States from 1993 to 2009. J. Clin. Microbiol. 49:2097-2101.
12. Hanage WP, et al. 2005. Invasiveness of serotypes and clones of Streptococcus pneumoniae among children in Finland. Infect. Immun. 73:431-435. (Pubitemid 40041136)
13. Hanna JN, Humphreys JL, Murphy DM. 2008. Invasive pneumococcal disease in Indigenous people in north Queensland: an update, 2005-2007. Med. J. Aust. 189:43-46.
14. Hicks LA, et al. 2007. Incidence of pneumococcal disease due to non-pneumococcal conjugate vaccine (PCV7) serotypes in the United States during the era of widespread PCV7 vaccination, 1998-2004. J. Infect. Dis. 196:1346-1354. (Pubitemid 351412007)
15. Hsieh Y, Lee W, Shao P, Chang L, Huang L. 2008. The transforming Streptococcus pneumoniae in the 21st century. Chang. Gung. Med. J. 31:117-124. (Pubitemid 351569808)
16. Kilpi T, Håhman et al. 2003. Protective efficacy of a second pneumococcal conjugate vaccine against pneumococcal acute otitis media in infants and children: randomized, controlled trial of a 7-valent pneumococcal polysaccharide-meningococcal outer membrane protein complex conjugate vaccine in 1666 children. Clin. Infect. Dis. 37:1155-1164.
17. Lehmann D, et al. 2010. The changing epidemiology of invasive pneumococcal disease in aboriginal and non-aboriginal western Australians from 1997 through 2007 and emergence of nonvaccine serotypes. Clin. Infect. Dis. 50:1477-1486.
18. Leimkugel J, et al. 2005. An outbreak of serotype 1 Streptococcus pneumoniae meningitis in northern Ghana with features that are characteristic of Neisseria meningitidis meningitis epidemics. J. Infect. Dis. 192:192-199. (Pubitemid 40993388)
19. McEllistrem MC, et al. 2005. Acute otitis media due to penicillin-nonsusceptible Streptococcus pneumoniae before and after the introduction of the pneumococcal conjugate vaccine. Clin. Infect. Dis. 40:1738-1744. (Pubitemid 40799941)
20. Melin M, Trzciński K, Meri S, Käyhty H, Väkeväinen M. 2010. The capsular serotype of Streptococcus pneumoniae is more important than the genetic background for resistance to complement. Infect. Immun. 78:5262-5270.
21. Moore MR, et al. 2008. Population snapshot of emergent Streptococcus pneumoniae serotype 19A in the United States, 2005. J. Infect. Dis. 197:1016-1027. (Pubitemid 351590031)
22. Muñoz-Almagro C, et al. 2008. Emergence of invasive pneumococcal disease caused by nonvaccine serotypes in the era of 7-valent conjugate vaccine. Clin. Infect. Dis. 46:174-182. (Pubitemid 351269154)
23. Obando I, et al. 2008. Pediatric parapneumonic empyema, Spain. Emerg. Infect. Dis. 14:1390-1397.
24. Pai R, Gertz RE, Whitney CG, Beall B, Active Bacterial Core Surveillance Team. 2005. Clonal association between Streptococcus pneumoniae serotype 23A, circulating within the United States, and an internationally dispersed clone of serotype 23F. J. Clin. Microbiol. 43:5440-5444. (Pubitemid 41612311)
25. Pilishvili T, et al. 2010. Sustained reductions in invasive pneumococcal disease in the era of conjugate vaccine. J. Infect. Dis. 201:32-41.
26. Porat N, Amit U, Givon-Lavi N, Leibovitz E, Dagan R. 2010. Increasing importance of multidrug-resistant serotype 6A Streptococcus pneumoniae clones in acute otitis media in southern Israel. Pediatr. Infect. Dis. J. 29:126-130.
27. Porat N, Barkai G, Jacobs MR, Trefler R, Dagan R. 2004. Four antibiotic-resistant Streptococcus pneumoniae clones unrelated to the pneumococcal conjugate vaccine serotypes, including 2 new serotypes, causing acute otitis media in southern Israel. J. Infect. Dis. 189:385-392. (Pubitemid 38210574)
28. Porat N, Park IH, Nahm MH, Dagan R. 2010. Differential circulation of Streptococcus pneumoniae serotype 6C clones in two Israeli pediatric populations. J. Clin. Microbiol. 48:4649-4651.
29. Sá-Leão R, et al. 2011. Analysis of invasiveness of pneumococcal serotypes and clones circulating in Portugal before widespread use of conjugate vaccines reveals heterogeneous behavior of clones expressing the same serotype. J. Clin. Microbiol. 49:1369-1375.
30. Sandgren A, et al. 2004. Effect of clonal and serotype-specific properties on the invasive capacity of Streptococcus pneumoniae. J. Infect. Dis. 189:785-796. (Pubitemid 38328178)
31. Shouval DS, Greenberg D, Givon-Lavi N, Porat N, Dagan R. 2006. Site-specific disease potential of individual Streptococcus pneumoniae serotypes in pediatric invasive disease, acute otitis media and acute conjunctivitis. Pediatr. Infect. Dis. J. 25:602-607. (Pubitemid 43995356)
32. Singleton RJ, et al. 2007. Invasive pneumococcal disease caused by nonvaccine serotypes among Alaska native children with high levels of 7-valent pneumococcal conjugate vaccine coverage. JAMA 297:1784-1792. (Pubitemid 46658647)
33. Weinberger DM, Malley R, Lipsitch M. 2011. Serotype replacement in disease after pneumococcal vaccination. Lancet 378:1962-1973.